Tirzepatide hot selling 99% Purity USA warehouse stock High Quality Beauty Slimming 5mg 10mg 15mg weight loss

 Product Details  

 Product P i c t u r e s 

 Product Introduction  

      Tirzepatide is a novel dual glucose -dependent otropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) developed by Eli Lilly and Company. Approved by the U.S. FDA in May 2022 under the brand name "Tirzepatide", it is primarily indicated for the treatment of type 2 diabetes mellitus.

      Tirzepatide represents a breakthrough in diabetes management by uniquely targeting both GIP and GLP-1 receptors, which enhances secretion, suppresses glucagon release, slows gastric emptying, and promotes satiety. This dual mechanism offers superior glycemic control and weight loss compared to traditional GLP-1 agonists like semaglutide.

      Clinical trials, including the "SURPASS" program , demonstrated tirzepatide’s efficacy . Participants achieved significant reductions in HbA1c (up to 2.4%) and substantial weight loss (averaging 12-15% of body weight at higher doses). These outcomes positioned it as a potential game-changer for patients with obesity-related type 2 diabetes. In late 2023, the FDA also approved tirzepatide (marketed as "Tirzepatide") for chronic weight management in adults with obesity or overweight conditions with weight-related comorbidities, expanding its therapeutic reach.

       Tirzepatide’s most common side effects include gastrointestinal issues such as nausea, diarrhea, and vomiting, which typically diminish over time. Its safety profile aligns with existing GLP-1 therapies, though long-term data are still being studied.

       Tirzepatide’s success underscores the growing emphasis on dual-agonist therapies for metabolic disorders. With robust clinical results and strong market adoption, it has rapidly become a blockbuster drug , offering hope for improved outcomes in diabetes and obesity care.

  Before and After Weight Loss  

    Our Advantages    

 Packing 

  Production Equipment  

 Company Profile 

 Trans porta tion Mo des 

P a y m e n t M o d e s